Global Compounding Pharmacies Market Size By Type (Oral Medications, Topical Medications), By Application (Medications for adults, Medication for veterinary purposes), By Region, And Segment Forecasts...

The Global Compounding Pharmacies Market was valued at USD 11.3 billion in 2023 and is expected to surpass USD 18.6 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2023–2031). The rising prevalence of chronic and age-related diseases, increasing demand for personalized medicine, and shortages of specific drug formulations are key factors driving the market. Compounding pharmacies play a vital role in creating customized medications tailored to the unique needs of individual patients when commercially available drugs are unsuitable.

Drivers

1. Growing Demand for Personalized Medicine

The trend toward patient-centric treatment is significantly boosting the compounding pharmacies market. These pharmacies can tailor drug dosages, delivery methods, and formulations to accommodate patient-specific requirements, such as allergies or pediatric dosages.

2. Drug Shortages and Discontinuations

As global supply chain disruptions and pharmaceutical production issues continue to create shortages of certain medications, compounding pharmacies fill critical gaps by formulating alternatives, maintaining patient access to essential treatments.

3. Increasing Geriatric Population

Older adults often require customized treatments due to polypharmacy and chronic conditions. Compounding pharmacies are increasingly utilized to create easy-to-consume formats like topical gels, liquid suspensions, or slow-release capsules suited to geriatric needs.

Restraints

1. Regulatory Complexity

The industry is subject to stringent regulations, particularly from agencies like the U.S. FDA and USP. Navigating varying regulatory frameworks globally can be burdensome and may impede market expansion.

2. Limited Reimbursement Policies

In many regions, compounded medications are not reimbursed under insurance plans, posing cost-related challenges for both providers and patients, and limiting the market's full potential.

Opportunity

1. Technological Advancements in Compounding Techniques

The integration of automation, robotics, and quality assurance technologies in compounding facilities enhances precision and safety. These advancements are expected to expand the scope and efficiency of compounding practices.

2. Expansion into Veterinary and Hormone Replacement Therapies (HRT)

There is a growing opportunity in compounding for pets and bio-identical hormone replacement therapies, especially as awareness and acceptance of personalized treatment grows in these segments.

Market by System Type Insights

Sterile Compounding Segment led the market in 2023, driven by the critical need for customized IV drugs, injectable medications, and ophthalmic solutions, particularly for hospital and clinical settings. This segment is expected to maintain its dominance due to stringent healthcare demands and rising hospital admissions.

Market by End-use Insights

Hospital Pharmacies accounted for the largest revenue share in 2023. With increasing hospitalization rates and demand for inpatient care, the need for compounding capabilities within hospitals is growing. Meanwhile, Community Pharmacies are witnessing a surge in demand for dermatological and pediatric formulations.

Market by Regional Insights

North America dominated the compounding pharmacies market in 2023, thanks to its advanced healthcare infrastructure, high incidence of chronic conditions, and favorable regulatory support in the U.S. market. However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period due to increasing healthcare investments, aging populations, and expanding awareness of customized medicine.

Competitive Scenario

Major players in the Global Compounding Pharmacies Market include Fagron, B. Braun Melsungen AG, PharMEDium Services (part of AmerisourceBergen), Wedgewood Pharmacy, Dougherty's Pharmacy, Institutional Pharmacy Solutions, Avella Specialty Pharmacy, and Triangle Compounding Pharmacy. Strategic developments such as facility expansions, regulatory compliance upgrades, and service diversification remain central to their growth strategies.

Scope of Work – Global Compounding Pharmacies Market

Report Metric Details

Market Size (2023) USD 11.3 Billion

Projected Market Size (2031) USD 18.6 Billion

CAGR (2023–2031) 6.6%

Market Segments By System Type (Sterile, Non-sterile), By End-use (Hospital Pharmacies, Community Pharmacies, Others), By Region

Growth Drivers Demand for personalized medicine, Drug shortages, Geriatric population growth

Opportunities Technological innovations, Veterinary and HRT applications

Key Market Developments

March 2023: Fagron expanded its U.S. compounding facility to enhance sterile product offerings and reduce lead times in delivering customized medications.

June 2024: B. Braun Melsungen AG introduced a new automated sterile compounding unit for hospital pharmacies in Europe, targeting enhanced safety and workflow efficiency.

January 2025: Wedgewood Pharmacy launched a new veterinary-focused compounding suite to meet growing demand in the animal healthcare segment.

FAQs

1) What is the current market size of the Global Compounding Pharmacies Market?

The Global Compounding Pharmacies Market was valued at USD 11.3 billion in 2023.

2) What is the major growth driver of the Global Compounding Pharmacies Market?

The increasing demand for personalized medicine and the role of compounding in addressing drug shortages are major growth drivers.

3) Which is the largest region during the forecast period in the Global Compounding Pharmacies Market?

North America is projected to remain the largest region due to its mature healthcare infrastructure and regulatory support.

4) Which segment accounted for the largest market share in Global Compounding Pharmacies Market?

The Sterile Compounding segment held the largest market share in 2023.

5) Who are the key market players in the Global Compounding Pharmacies Market?

Key players include Fagron, B. Braun Melsungen AG, PharMEDium Services, Wedgewood Pharmacy, and Avella Specialty Pharmacy.